Modulation of FGF pathway signaling and vascular differentiation using designed oligomeric assemblies
N. I. Edman, R. L. Redler, A. Phal, T. Schlichthaerle, S. R. Srivatsan, A. Etemadi, S. An, A. Favor, D. Ehnes, Z. Li, F. Praetorius, M. Gordon, W. Yang, B. Coventry, D. R. Hicks, L. Cao, N. Bethel, P. Heine, A. N. Murray, S. Gerben, L. Carter, M. Miranda, B. Negahdari, S. Lee, C. Trapnell, , D. Baker
Abstract
Growth factors and cytokines signal by binding to the extracellular domains of their receptors and drive association and transphosphorylation of the receptor intracellular tyrosine kinase domains, initiating downstream signaling cascades. To enable systematic exploration of how receptor valency and geometry affects signaling outcomes, we designed cyclic homo-oligomers with up to 8 subunits using repeat protein building blocks that can be modularly extended. By incorporating a de novo designed fibroblast growth-factor receptor (FGFR) binding module into these scaffolds, we generated a series of synthetic signaling ligands that exhibit potent valency- and geometry-dependent Ca2+ release and MAPK pathway activation. The high specificity of the designed agonists reveal distinct roles for two FGFR splice variants in driving endothelial and mesenchymal cell fates during early vascular development. The ability to incorporate receptor binding domains and repeat extensions in a modular fashion makes our designed scaffolds broadly useful for probing and manipulating cellular signaling pathways. HighlightsO_LIDe novo designed cyclic oligomers with tunable geometric properties C_LIO_LICyclic, homo-oligomeric FGFR binding modules induce geometry- and valency-dependent activity of isoform-specific FGF signaling C_LIO_LIModulation of FGFR isoform activity controls bifurcation of endothelial and mesenchymal fate during vascular development C_LIO_LIC-isoform activation favors arterial endothelial cell formation while B-isoform induces pericyte differentiation C_LI Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=135 SRC="FIGDIR/small/532666v1_ufig1.gif" ALT="Figure 1"> View larger version (35K): org.highwire.dtl.DTLVardef@151f6eforg.highwire.dtl.DTLVardef@2ae877org.highwire.dtl.DTLVardef@103e0d1org.highwire.dtl.DTLVardef@19cd695_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Ligand bias underlies differential signaling of multiple FGFs via FGFR1
K. A. Karl, K. Hristova, … B. Fafilek·bioRxiv·Jan 6, 2022
- Direct cell reprogramming by a designed agonist inducing HER2-FGFR proximity
Riya Keshri, Marc Expòsit, … Hannele Ruohola‐Baker·bioRxiv·Oct 12, 2025
- FGF signaling in development beyond canonical pathways
Ayan T. Ray, Pierre Mazot, … Philippe M. Soriano·Genes & DevelopmentPeer-reviewed·Dec 1, 2020
- Diverse Fgfr1 signaling pathways and endocytic trafficking regulate early mesoderm development
James F. Clark, Philippe M. Soriano·bioRxiv·Feb 16, 2024
- Tuning of granulopoietic signaling by de novo designed agonists
T. Ullrich, C. Pollmann, … M. ElGamacy·bioRxiv·Nov 25, 2023
- Recombinant expression in E. coli of human FGFR2 with its transmembrane and extracellular domains
A. Bajinting, H. L. Ng·bioRxiv·May 25, 2017